In the STEP-4 clinical trials, participants who discontinued the medication began to regain weight within a few months
Long-Term Strategy Most patients do well with 2 to 3 cycles per year , especially when combined with other supportive therapies such as: MOTS-c for mitochondrial optimization Tesamorelin for visceral fat reduction AOD-9604 for enhanced fat burning Follistatin to support lean muscle gains Who Benefits Most from 5-Amino-1MQ
For more detailed assessment, periodic blood work including metabolic panels, lipid profiles, and inflammatory markers can provide objective data on how the compound affects health parameters
Technical Specifications Storage & Quality Assurance Strict adherence to climate-controlled, cold-chain storage is mandatory to preserve the structural integrity of this compound
Phase 2 trials (Jastreboff et al., NEJM, 2023) have shown it to be highly effective for weight reduction in adults with obesity
Reported or proposed issue Pregnancy, breastfeeding, children, liver disease, or cancer history Evidence source No direct human safety data Known or theoretical